Ceramide, AIDS and long-term survivors
- 31 January 1996
- journal article
- other
- Published by Elsevier in Immunology Today
- Vol. 17 (1) , 48
- https://doi.org/10.1016/0167-5699(96)80570-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Does endotoxin stimulate cells by mimicking ceramide?Immunology Today, 1995
- Ceramide: an endogenous regulator of apoptosis and growth suppresionImmunology Today, 1995
- Absence of Intact nef Sequences in a Long-Term Survivor with Nonprogressive HIV-1 InfectionNew England Journal of Medicine, 1995
- Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995
- Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1995
- Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase.The Journal of Experimental Medicine, 1994
- Stimulation of Human Immunodeficiency Virus Type 1 Expression by CeramideAIDS Research and Human Retroviruses, 1994
- Involvement of the sphingomyelin pathway in autocrine tumor necrosis factor signaling for human immunodeficiency virus production in chronically infected HL-60 cellsBlood, 1994
- Changes in bioactive lipids, alkylacylglycerol and ceramide, occur in HIV-infected cellsBiochemical and Biophysical Research Communications, 1992